Curatively intended surgery for exocrine pancreatic cancer
(1994) In The Gastroenterologist 2(1). p.20-26- Abstract
Resective surgery for exocrine pancreatic cancer can currently be performed with little or no hospital mortality. The operation is most often performed as a Whipple resection, but several modifications (e.g., subtotal pancreatectomy) have been advocated. The pylorus-preserving modification has gained in popularity, although its ability to remove all lymph nodes has been questioned. Total pancreatectomy, always causing brittle diabetes, is performed in less than 10% of patients, and then more and more often as part of an extended operation, including major vessels, which must be substituted. Adjuvant treatment with impact on long-term survival is lacking; however, the results of curatively intended surgery for exocrine pancreatic cancer... (More)
Resective surgery for exocrine pancreatic cancer can currently be performed with little or no hospital mortality. The operation is most often performed as a Whipple resection, but several modifications (e.g., subtotal pancreatectomy) have been advocated. The pylorus-preserving modification has gained in popularity, although its ability to remove all lymph nodes has been questioned. Total pancreatectomy, always causing brittle diabetes, is performed in less than 10% of patients, and then more and more often as part of an extended operation, including major vessels, which must be substituted. Adjuvant treatment with impact on long-term survival is lacking; however, the results of curatively intended surgery for exocrine pancreatic cancer is slowly getting better.
(Less)
- author
- Andrén-Sandberg, A. LU and Hafström, A. LU
- publishing date
- 1994-01-01
- type
- Contribution to journal
- publication status
- published
- in
- The Gastroenterologist
- volume
- 2
- issue
- 1
- pages
- 7 pages
- publisher
- Little Brown & Co
- external identifiers
-
- pmid:7914459
- scopus:0028398987
- ISSN
- 1065-2477
- language
- English
- LU publication?
- no
- id
- ba1df31c-adcd-4315-8c85-166c4e1ff457
- date added to LUP
- 2020-05-09 08:37:41
- date last changed
- 2024-01-02 10:56:27
@article{ba1df31c-adcd-4315-8c85-166c4e1ff457, abstract = {{<p>Resective surgery for exocrine pancreatic cancer can currently be performed with little or no hospital mortality. The operation is most often performed as a Whipple resection, but several modifications (e.g., subtotal pancreatectomy) have been advocated. The pylorus-preserving modification has gained in popularity, although its ability to remove all lymph nodes has been questioned. Total pancreatectomy, always causing brittle diabetes, is performed in less than 10% of patients, and then more and more often as part of an extended operation, including major vessels, which must be substituted. Adjuvant treatment with impact on long-term survival is lacking; however, the results of curatively intended surgery for exocrine pancreatic cancer is slowly getting better.</p>}}, author = {{Andrén-Sandberg, A. and Hafström, A.}}, issn = {{1065-2477}}, language = {{eng}}, month = {{01}}, number = {{1}}, pages = {{20--26}}, publisher = {{Little Brown & Co}}, series = {{The Gastroenterologist}}, title = {{Curatively intended surgery for exocrine pancreatic cancer}}, volume = {{2}}, year = {{1994}}, }